Concepts (169)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Asthma | 24 | 2016 | 363 | 2.300 |
Why?
|
Puerto Rico | 25 | 2016 | 1352 | 0.590 |
Why?
|
Integrons | 1 | 2015 | 1 | 0.550 |
Why?
|
Genetic Variation | 2 | 2015 | 328 | 0.550 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2015 | 30 | 0.530 |
Why?
|
Escherichia coli Infections | 1 | 2015 | 39 | 0.520 |
Why?
|
Child | 23 | 2016 | 2875 | 0.450 |
Why?
|
Escherichia coli | 1 | 2015 | 436 | 0.430 |
Why?
|
Anxiety Disorders | 2 | 2012 | 281 | 0.410 |
Why?
|
Capacity Building | 4 | 2015 | 78 | 0.380 |
Why?
|
Depressive Disorder | 1 | 2012 | 166 | 0.370 |
Why?
|
Allergens | 3 | 2014 | 58 | 0.350 |
Why?
|
Vitamin D Deficiency | 3 | 2016 | 94 | 0.350 |
Why?
|
Adolescent | 20 | 2016 | 5035 | 0.330 |
Why?
|
Obesity | 3 | 2013 | 965 | 0.320 |
Why?
|
Dust | 3 | 2014 | 51 | 0.270 |
Why?
|
Hypersensitivity | 2 | 2016 | 28 | 0.260 |
Why?
|
Violence | 2 | 2016 | 126 | 0.250 |
Why?
|
Bronchodilator Agents | 3 | 2016 | 24 | 0.200 |
Why?
|
Male | 22 | 2016 | 18870 | 0.200 |
Why?
|
Humans | 29 | 2016 | 34853 | 0.200 |
Why?
|
Logistic Models | 6 | 2016 | 894 | 0.200 |
Why?
|
Vital Capacity | 3 | 2016 | 38 | 0.200 |
Why?
|
Case-Control Studies | 8 | 2016 | 1056 | 0.200 |
Why?
|
Female | 21 | 2016 | 19873 | 0.190 |
Why?
|
Body Mass Index | 3 | 2013 | 775 | 0.190 |
Why?
|
Immunoglobulin E | 2 | 2016 | 54 | 0.170 |
Why?
|
Community-Based Participatory Research | 2 | 2014 | 292 | 0.170 |
Why?
|
Receptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type I | 2 | 2015 | 4 | 0.170 |
Why?
|
Severity of Illness Index | 4 | 2016 | 608 | 0.160 |
Why?
|
Genome-Wide Association Study | 3 | 2015 | 271 | 0.160 |
Why?
|
Cities | 2 | 2015 | 61 | 0.160 |
Why?
|
Folic Acid Deficiency | 1 | 2016 | 6 | 0.140 |
Why?
|
Genotype | 2 | 2015 | 641 | 0.140 |
Why?
|
Firearms | 1 | 2016 | 11 | 0.140 |
Why?
|
Disk Diffusion Antimicrobial Tests | 1 | 2015 | 1 | 0.140 |
Why?
|
Weapons | 1 | 2015 | 5 | 0.140 |
Why?
|
Multivariate Analysis | 5 | 2016 | 570 | 0.130 |
Why?
|
Interleukin-17 | 1 | 2015 | 54 | 0.130 |
Why?
|
Education, Public Health Professional | 1 | 2015 | 18 | 0.130 |
Why?
|
Quantitative Trait Loci | 1 | 2015 | 68 | 0.130 |
Why?
|
Cluster Analysis | 1 | 2015 | 188 | 0.130 |
Why?
|
Anti-Infective Agents | 1 | 2015 | 62 | 0.130 |
Why?
|
Hospitals | 1 | 2015 | 86 | 0.130 |
Why?
|
Mexico | 1 | 2015 | 223 | 0.130 |
Why?
|
Hypersensitivity, Immediate | 1 | 2014 | 11 | 0.130 |
Why?
|
DNA, Bacterial | 1 | 2015 | 184 | 0.130 |
Why?
|
Air Pollution, Indoor | 1 | 2014 | 40 | 0.120 |
Why?
|
Academies and Institutes | 1 | 2014 | 35 | 0.120 |
Why?
|
Rhinitis, Allergic, Perennial | 1 | 2013 | 5 | 0.120 |
Why?
|
Medicine | 1 | 2014 | 31 | 0.120 |
Why?
|
Stress, Physiological | 1 | 2015 | 137 | 0.120 |
Why?
|
Polymerase Chain Reaction | 1 | 2015 | 430 | 0.120 |
Why?
|
Evidence-Based Practice | 1 | 2014 | 41 | 0.120 |
Why?
|
Environmental Exposure | 1 | 2016 | 207 | 0.120 |
Why?
|
Polymorphism, Single Nucleotide | 5 | 2015 | 638 | 0.120 |
Why?
|
Prevalence | 3 | 2014 | 1425 | 0.120 |
Why?
|
Health Services Research | 1 | 2014 | 133 | 0.120 |
Why?
|
Sequence Analysis, DNA | 1 | 2015 | 455 | 0.120 |
Why?
|
Fungi | 1 | 2014 | 86 | 0.120 |
Why?
|
Breast Feeding | 1 | 2014 | 105 | 0.110 |
Why?
|
Phenotype | 1 | 2015 | 650 | 0.110 |
Why?
|
Premature Birth | 1 | 2013 | 71 | 0.110 |
Why?
|
Adiposity | 1 | 2013 | 145 | 0.110 |
Why?
|
Odds Ratio | 4 | 2015 | 517 | 0.110 |
Why?
|
Interview, Psychological | 1 | 2012 | 58 | 0.110 |
Why?
|
Genetic Predisposition to Disease | 1 | 2015 | 528 | 0.100 |
Why?
|
Residence Characteristics | 1 | 2014 | 301 | 0.100 |
Why?
|
Feeding Behavior | 1 | 2015 | 418 | 0.100 |
Why?
|
Caregivers | 2 | 2011 | 167 | 0.100 |
Why?
|
Health Literacy | 1 | 2013 | 100 | 0.100 |
Why?
|
Sex Distribution | 1 | 2012 | 212 | 0.100 |
Why?
|
Family | 2 | 2010 | 162 | 0.100 |
Why?
|
Skin Tests | 3 | 2016 | 13 | 0.100 |
Why?
|
Young Adult | 4 | 2015 | 4012 | 0.100 |
Why?
|
Parents | 1 | 2013 | 288 | 0.090 |
Why?
|
Social Class | 1 | 2012 | 228 | 0.090 |
Why?
|
Depressive Disorder, Major | 1 | 2011 | 102 | 0.090 |
Why?
|
Health Services Accessibility | 1 | 2014 | 531 | 0.090 |
Why?
|
Stress, Psychological | 1 | 2015 | 541 | 0.090 |
Why?
|
Linear Models | 3 | 2015 | 253 | 0.090 |
Why?
|
Lung | 1 | 2012 | 413 | 0.090 |
Why?
|
Minority Groups | 1 | 2014 | 537 | 0.090 |
Why?
|
Health Promotion | 1 | 2015 | 588 | 0.090 |
Why?
|
Diet | 1 | 2015 | 747 | 0.090 |
Why?
|
Respiratory Function Tests | 3 | 2013 | 49 | 0.080 |
Why?
|
Sex Factors | 1 | 2012 | 859 | 0.080 |
Why?
|
Chronic Disease | 1 | 2012 | 469 | 0.080 |
Why?
|
Anxiety | 1 | 2015 | 705 | 0.080 |
Why?
|
Biomedical Research | 1 | 2012 | 371 | 0.080 |
Why?
|
Healthcare Disparities | 1 | 2012 | 446 | 0.080 |
Why?
|
Health Education | 1 | 2010 | 304 | 0.070 |
Why?
|
Cross-Sectional Studies | 4 | 2015 | 2561 | 0.070 |
Why?
|
Patient Education as Topic | 1 | 2007 | 207 | 0.070 |
Why?
|
Forced Expiratory Volume | 2 | 2016 | 68 | 0.070 |
Why?
|
Adult | 4 | 2015 | 11034 | 0.070 |
Why?
|
Health Knowledge, Attitudes, Practice | 2 | 2010 | 790 | 0.060 |
Why?
|
Socioeconomic Factors | 3 | 2016 | 1003 | 0.060 |
Why?
|
Risk Factors | 3 | 2015 | 3414 | 0.060 |
Why?
|
Child, Preschool | 3 | 2013 | 1318 | 0.050 |
Why?
|
Vitamin D | 2 | 2016 | 176 | 0.050 |
Why?
|
Treatment Outcome | 2 | 2015 | 1349 | 0.050 |
Why?
|
Program Evaluation | 2 | 2015 | 316 | 0.050 |
Why?
|
Practice Guidelines as Topic | 2 | 2014 | 187 | 0.050 |
Why?
|
Retrospective Studies | 2 | 2015 | 1961 | 0.040 |
Why?
|
Administration, Inhalation | 1 | 2016 | 75 | 0.030 |
Why?
|
Hypoxanthine Phosphoribosyltransferase | 1 | 2015 | 9 | 0.030 |
Why?
|
Albuterol | 1 | 2015 | 9 | 0.030 |
Why?
|
Folic Acid | 1 | 2016 | 46 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2016 | 48 | 0.030 |
Why?
|
Statistics as Topic | 1 | 2016 | 111 | 0.030 |
Why?
|
Cystic Fibrosis Transmembrane Conductance Regulator | 1 | 2015 | 12 | 0.030 |
Why?
|
Rhode Island | 1 | 2015 | 15 | 0.030 |
Why?
|
Dairy Products | 1 | 2015 | 33 | 0.030 |
Why?
|
Fibroblast Growth Factors | 1 | 2015 | 34 | 0.030 |
Why?
|
Receptors, Adrenergic, beta-2 | 1 | 2015 | 17 | 0.030 |
Why?
|
Organizational Case Studies | 1 | 2015 | 29 | 0.030 |
Why?
|
Models, Organizational | 1 | 2015 | 33 | 0.030 |
Why?
|
Genetic Markers | 1 | 2015 | 118 | 0.030 |
Why?
|
Transportation | 1 | 2014 | 26 | 0.030 |
Why?
|
Endotoxins | 1 | 2014 | 18 | 0.030 |
Why?
|
Antigens, Dermatophagoides | 1 | 2014 | 7 | 0.030 |
Why?
|
Pyroglyphidae | 1 | 2014 | 4 | 0.030 |
Why?
|
Intracellular Signaling Peptides and Proteins | 1 | 2015 | 184 | 0.030 |
Why?
|
Vegetables | 1 | 2015 | 135 | 0.030 |
Why?
|
Science | 1 | 2014 | 17 | 0.030 |
Why?
|
Air Pollution | 1 | 2014 | 59 | 0.030 |
Why?
|
Fruit | 1 | 2015 | 159 | 0.030 |
Why?
|
Waist-Hip Ratio | 1 | 2013 | 32 | 0.030 |
Why?
|
Disease Progression | 1 | 2016 | 580 | 0.030 |
Why?
|
Waist Circumference | 1 | 2013 | 82 | 0.030 |
Why?
|
Carrier Proteins | 1 | 2015 | 287 | 0.030 |
Why?
|
Clinical Competence | 1 | 2014 | 124 | 0.030 |
Why?
|
Down-Regulation | 1 | 2015 | 420 | 0.030 |
Why?
|
Infant, Premature | 1 | 2013 | 128 | 0.030 |
Why?
|
Animals | 3 | 2014 | 14307 | 0.030 |
Why?
|
Health Services Needs and Demand | 1 | 2014 | 143 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2014 | 424 | 0.030 |
Why?
|
CpG Islands | 1 | 2013 | 91 | 0.030 |
Why?
|
Educational Status | 1 | 2014 | 295 | 0.030 |
Why?
|
Focus Groups | 1 | 2014 | 307 | 0.030 |
Why?
|
Proteins | 1 | 2015 | 352 | 0.030 |
Why?
|
Mice | 2 | 2014 | 5668 | 0.030 |
Why?
|
Needs Assessment | 1 | 2014 | 159 | 0.030 |
Why?
|
Incidence | 1 | 2015 | 882 | 0.030 |
Why?
|
Cooperative Behavior | 1 | 2014 | 205 | 0.030 |
Why?
|
Alleles | 1 | 2013 | 284 | 0.030 |
Why?
|
Community-Institutional Relations | 1 | 2014 | 171 | 0.030 |
Why?
|
Follow-Up Studies | 1 | 2014 | 964 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2014 | 871 | 0.030 |
Why?
|
Algorithms | 1 | 2014 | 435 | 0.030 |
Why?
|
Infant | 1 | 2014 | 1014 | 0.020 |
Why?
|
Chi-Square Distribution | 1 | 2011 | 213 | 0.020 |
Why?
|
Epigenesis, Genetic | 1 | 2013 | 198 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2015 | 1152 | 0.020 |
Why?
|
Cohort Studies | 1 | 2014 | 1422 | 0.020 |
Why?
|
Interviews as Topic | 1 | 2011 | 356 | 0.020 |
Why?
|
DNA Methylation | 1 | 2013 | 301 | 0.020 |
Why?
|
Gene Expression Regulation | 1 | 2015 | 968 | 0.020 |
Why?
|
Comorbidity | 1 | 2011 | 606 | 0.020 |
Why?
|
Cultural Competency | 1 | 2010 | 120 | 0.020 |
Why?
|
Pregnancy | 1 | 2013 | 1503 | 0.020 |
Why?
|
Anti-Asthmatic Agents | 1 | 2007 | 30 | 0.020 |
Why?
|
Culture | 1 | 2007 | 162 | 0.020 |
Why?
|
United States | 1 | 2016 | 3894 | 0.020 |
Why?
|
Poverty | 1 | 2007 | 316 | 0.020 |
Why?
|
Health Status Disparities | 1 | 2010 | 583 | 0.010 |
Why?
|
Aged | 1 | 2013 | 6448 | 0.010 |
Why?
|
Middle Aged | 1 | 2013 | 9642 | 0.010 |
Why?
|